Tramadol for Labour Analgesia in Low Risk Primiparous Women

• Status: Completed
• Trial end date: 2013-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

Tramadol is a centrally acting synthetic analgesic used to treat moderate to moderately severe pain. It has been previously evaluated as a method to reduce pain during labour, but there is always some fear related to its effects (neonatal respiratory depression). The purpose of our study was to evaluate the efficacy of subcutaneous tramadol in regards to pain during labour, duration of labour and neonatal outcomes.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Saint Thomas Hospital, Panama
• Treatments: Tramadol

Criteria

Inclusion Criteria:

• Gestational age between 37 and 40 6/7 weeks

• Primiparous patient

• Singleton

• 4 to 5 cms of dilation

• Intact membranes or spontaneous rupture of membranes less than 2 hours

• Fetus in a vertex presentation

• Gynecoid pelvis by clinical examination

Exclusion Criteria:

• Multiparous

• Multiple pregnancies

• Any pathology

• Induction of labour with prostaglandins